ASCO 2022 Updates on the Phase II DANTE Trial: Surgical & Pathological Outcome in Pts Receiving Perioperative Atezo + FLOT vs. FLOT Alone for Resectable GEJ

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO 2022 Updates on the Phase II DANTE Trial: Surgical & Pathological Outcome in Pts Receiving Perioperative Atezo + FLOT vs. FLOT Alone for Resectable GEJ

By Total Health FEATURING Rachna Shroff

84 views

August 31, 2022

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Cancer Updates GI and Lung

Thu, Mar 13, 2025

See 1 other

Total Health

Best of ASCO GI Cancer

Sat, Apr 5, 2025

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

2.3K views

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

1.4K views

Year in Review 2024 - Early Stage Upper GI Cancers

Oncology 2024 Year in Review

N. Uboha

349 views

Year in Review 2024 - Advanced Stage Upper GI Cancers

Oncology 2024 Year in Review

N. Uboha

332 views

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

447 views

Treatment Updates in the Management of Metastatic Gastroesophageal C…

Total Health

S. Chokshi

263 views

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.2K views

Esophageal Cancer Case Discussion: Workup and Updated Treatment Opti…

Yale Cancer Center

P. Kunz, L. Baum, K. Du, S. Khan, J. Kortmansky

251 views

New

ASCO® GI 2025 Summary: Meta-Analysis of Phase II/III RCTs to Evaluat…

Insights from 2025 ASCO® GI Annual Meeting

K. Thein

164 views

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

324 views

New

ASCO® GI 2025 Insights: Ph2 Study of Neoadjuvant FLOT for Resectable…

Insights from 2025 ASCO® GI Annual Meeting

S. Yamamoto

122 views

Advances in Targeted Agents in Gastroesophageal Cancer

Debbie's Dream Foundation

D. Ilson

149 views

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, A. Turk, K. Spencer, M. Cecchini

555 views

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

151 views

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Debbie's Dream Foundation

S. Klempner

189 views

ESMO 2024 Summary: Perioperative Upper GI Treatment Highlights

COR2ED The Heart of Medical Education

E. Smyth, S. Klempner

124 views

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

180 views

ESOPEC Trial: Neoadjuvant Chemoradiation vs. Perioperative Chemother…

ecancer

T. Brunner

73 views

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Shankaran

242 views

AUTOPLAY

Login

Login

Join VuMedi

ASCO 2022 Updates on the Phase II DANTE Trial: Surgical & Pathological Outcome in Pts Receiving Perioperative Atezo + FLOT vs. FLOT Alone for Resectable GEJ

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Related Videos

Cancer Updates GI and Lung

Best of ASCO GI Cancer

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

Year in Review 2024 - Early Stage Upper GI Cancers

Year in Review 2024 - Advanced Stage Upper GI Cancers

Recent Updates in Upper Gl Cancers

Treatment Updates in the Management of Metastatic Gastroesophageal C…

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Esophageal Cancer Case Discussion: Workup and Updated Treatment Opti…

ASCO® GI 2025 Summary: Meta-Analysis of Phase II/III RCTs to Evaluat…

ESMO 2024 Summary: Developmental Therapeutics Highlights

ASCO® GI 2025 Insights: Ph2 Study of Neoadjuvant FLOT for Resectable…

Advances in Targeted Agents in Gastroesophageal Cancer

Hyperprogression in Cancer Treated With Immunotherapy

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

Gastroesophageal Cancer Updates From 2024 Summer Conferences

ESMO 2024 Summary: Perioperative Upper GI Treatment Highlights

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

ESOPEC Trial: Neoadjuvant Chemoradiation vs. Perioperative Chemother…

Overview of Esophageal & Gastric Cancer Diagnosis & Staging